Progress in chimerism analysis in childhood malignancies - the dilemma of biostatistical considerations and ethical implications

被引：18

作者：

Klingebiel, T ^{[1
]}

Niethammer, D

Dietz, K

Bader, P

机构：

[1] Univ Childrens Hosp 3, Frankfurt, Germany

[2] Univ Childrens Hosp Tubingen, Tubingen, Germany

[3] Inst Biomath, Tubingen, Germany

来源：

LEUKEMIA | 2001年 / 15卷 / 12期

关键词：

D O I：

10.1038/sj.leu.2402315

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1989 / 1991

页数：3

共 15 条

[1] ARMITAGE P, 1998, STAT METHODS MED RES, P195
[2] Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT
Bader, P
Beck, J
Frey, A
Schlegel, PG
Hebarth, H
Handgretinger, R
Einsele, H
Niemeyer, C
Benda, N
Faul, C
Kanz, L
Niethammer, D
Klingebiel, T
[J]. BONE MARROW TRANSPLANTATION, 1998, 21 (05) : 487 - 495
[3] Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children
Bader, P
Klingebiel, T
Schaudt, A
Theurer-Mainka, U
Handgretinger, R
Lang, P
Niethammer, D
Beck, JF
[J]. LEUKEMIA, 1999, 13 (12) : 2079 - 2086
[4] Bader P, 1996, ANTICANCER RES, V16, P1759
[5] Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: Is there an option to prevent relapse?
Bader, P
Beck, J
Schlegel, PG
Handgretinger, R
Niethammer, D
Klingebiel, T
[J]. BONE MARROW TRANSPLANTATION, 1997, 20 (01) : 79 - 81
[6] Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: The impact of quantitative PCR analysis for prediction of relapse and graft rejection in children
Bader, P
Holle, W
Klingebiel, T
Handgretinger, R
Benda, N
Schlegel, PG
Niethammer, D
Beck, J
[J]. BONE MARROW TRANSPLANTATION, 1997, 19 (07) : 697 - 702
[7] Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection
Dubovsky, J
Daxberger, H
Fritsch, G
Printz, D
Peters, C
Matthes, S
Gadner, H
Lion, T
[J]. LEUKEMIA, 1999, 13 (12) : 2060 - 2069
[8] GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS
KOLB, HJ
SCHATTENBERG, A
GOLDMAN, JM
HERTENSTEIN, B
JACOBSEN, N
ARCESE, W
LJUNGMAN, P
FERRANT, A
VERDONCK, L
NIEDERWIESER, D
VANRHEE, F
MITTERMUELLER, J
DEWITTE, T
HOLLER, E
ANSARI, H
[J]. BLOOD, 1995, 86 (05) : 2041 - 2050
[9] Clinical trials and rare diseases: A way out of a conundrum
Lilford, RJ
Thornton, JG
Braunholtz, D
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7020): : 1621 - 1625
[10] Chimerism testing after allogeneic stem cell transplantation:: importance of timing and optimal technique for chimerism testing in different clinical-biological situations
Lion, T
Muller-Bérat, N
[J]. LEUKEMIA, 1999, 13 (12) : 2059 - 2059

← 1 2 →